首页 > 最新文献

International Journal of Pharmacy Practice最新文献

英文 中文
Patient perspectives on the vital primary care role of community pharmacists in Nova Scotia, Canada: qualitative findings from the PUPPY Study. 患者对加拿大新斯科舍省社区药剂师在初级保健中的重要作用的看法:PUPPY 研究的定性结果。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-05-07 DOI: 10.1093/ijpp/riae008
Jennifer E Isenor, Lauren Renaud, Maria Mathews, Bobbi Morrison, Andrea L Murphy, Andrea Bishop, Susan K Bowles, Natalie Kennie-Kaulbach, Sarah Peddle, Mylaine Breton, Michael E Green, Emily G Marshall

Objectives: Community pharmacists play an important role in primary care access and delivery for all patients, including patients with a family physician or nurse practitioner ("attached") and patients without a family physician or nurse practitioner ("unattached"). During the COVID-19 pandemic, community pharmacists were accessible care providers for unattached patients and patients who had difficulty accessing their usual primary care providers ("semi-attached"). Before and during the pandemic, pharmacist services expanded in several Canadian provinces. The aim of this qualitative study was to explore patient experiences receiving care from community pharmacists, and their perspectives on the scope of practice of community pharmacists.

Methods: Fifteen patients in Nova Scotia, Canada, were interviewed. Participant narratives pertaining to pharmacist care were analyzed thematically.

Key findings: Attached, "semi-attached," and unattached patients valued community pharmacists as a cornerstone of care and sought pharmacists for a variety of health services, including triaging and system navigation. Patients spoke positively about expanding the scope of practice for community pharmacists, and better optimization of pharmacists in primary care.

Conclusions: System decision-makers should consider the positive role community pharmacists can play in achieving primary care across the Quintuple Aim (population health, patient and provider experiences, reducing costs, and supporting equity in health).

目标:社区药剂师在为所有患者(包括有家庭医生或执业护士的患者("有家庭医生或执业护士")和没有家庭医生或执业护士的患者("无家庭医生或执业护士"))提供初级医疗服务方面发挥着重要作用。在 COVID-19 大流行期间,社区药剂师是未随访患者和难以获得其惯常初级保健提供者("半随访")的患者可获得的保健提供者。在大流行之前和期间,药剂师服务在加拿大多个省份得到了扩展。这项定性研究旨在探讨患者接受社区药剂师护理的经历,以及他们对社区药剂师执业范围的看法:方法:对加拿大新斯科舍省的 15 名患者进行了访谈。对参与者有关药剂师护理的叙述进行了专题分析:有联系、"半联系 "和无联系的患者都认为社区药剂师是医疗服务的基石,并寻求药剂师提供各种医疗服务,包括分诊和系统导航。患者对扩大社区药剂师的执业范围以及更好地优化药剂师在初级保健中的作用给予了积极评价:系统决策者应考虑社区药剂师在实现初级医疗保健的五重目标(人口健康、患者和医疗服务提供者体验、降低成本和支持健康公平)中可发挥的积极作用。
{"title":"Patient perspectives on the vital primary care role of community pharmacists in Nova Scotia, Canada: qualitative findings from the PUPPY Study.","authors":"Jennifer E Isenor, Lauren Renaud, Maria Mathews, Bobbi Morrison, Andrea L Murphy, Andrea Bishop, Susan K Bowles, Natalie Kennie-Kaulbach, Sarah Peddle, Mylaine Breton, Michael E Green, Emily G Marshall","doi":"10.1093/ijpp/riae008","DOIUrl":"10.1093/ijpp/riae008","url":null,"abstract":"<p><strong>Objectives: </strong>Community pharmacists play an important role in primary care access and delivery for all patients, including patients with a family physician or nurse practitioner (\"attached\") and patients without a family physician or nurse practitioner (\"unattached\"). During the COVID-19 pandemic, community pharmacists were accessible care providers for unattached patients and patients who had difficulty accessing their usual primary care providers (\"semi-attached\"). Before and during the pandemic, pharmacist services expanded in several Canadian provinces. The aim of this qualitative study was to explore patient experiences receiving care from community pharmacists, and their perspectives on the scope of practice of community pharmacists.</p><p><strong>Methods: </strong>Fifteen patients in Nova Scotia, Canada, were interviewed. Participant narratives pertaining to pharmacist care were analyzed thematically.</p><p><strong>Key findings: </strong>Attached, \"semi-attached,\" and unattached patients valued community pharmacists as a cornerstone of care and sought pharmacists for a variety of health services, including triaging and system navigation. Patients spoke positively about expanding the scope of practice for community pharmacists, and better optimization of pharmacists in primary care.</p><p><strong>Conclusions: </strong>System decision-makers should consider the positive role community pharmacists can play in achieving primary care across the Quintuple Aim (population health, patient and provider experiences, reducing costs, and supporting equity in health).</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"216-222"},"PeriodicalIF":1.8,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extent of community pharmacists' care of clients with depression in Enugu, Nigeria: a cross-sectional survey. 尼日利亚埃努古社区药剂师对抑郁症患者的护理程度:横断面调查。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riad088
Chibueze Anosike, Maxwell Ogochukwu Adibe, Desmond Nnia Ani

Background: Community pharmacists play a crucial role in the care of people with depression. This study aimed to evaluate the level of care provided by community pharmacists for clients with depression in Enugu, Nigeria.

Methods: A cross-sectional survey was conducted among randomly selected community pharmacists in Enugu, Nigeria. The data obtained were analysed descriptively.

Key findings: Approximately 25% of pharmacists perform depression screening, and 14.4% refer clients to psychiatrists. Pharmacists rarely provide information on antidepressant dosage, side effects, frequency, and duration.

Conclusion: Community pharmacists in Enugu are not providing effective care to depressed patients. Thus, appropriate interventions are recommended.

背景:社区药剂师在为抑郁症患者提供护理方面发挥着至关重要的作用。本研究旨在评估尼日利亚埃努古市社区药剂师为抑郁症患者提供的护理水平:方法:对尼日利亚埃努古市随机抽取的社区药剂师进行了横断面调查。主要发现:约 25% 的药剂师会对抑郁症患者进行筛查:约 25% 的药剂师会进行抑郁症筛查,14.4% 的药剂师会将患者转介给精神科医生。药剂师很少提供有关抗抑郁药物剂量、副作用、频率和持续时间的信息:结论:埃努古的社区药剂师没有为抑郁症患者提供有效的治疗。因此,建议采取适当的干预措施。
{"title":"Extent of community pharmacists' care of clients with depression in Enugu, Nigeria: a cross-sectional survey.","authors":"Chibueze Anosike, Maxwell Ogochukwu Adibe, Desmond Nnia Ani","doi":"10.1093/ijpp/riad088","DOIUrl":"10.1093/ijpp/riad088","url":null,"abstract":"<p><strong>Background: </strong>Community pharmacists play a crucial role in the care of people with depression. This study aimed to evaluate the level of care provided by community pharmacists for clients with depression in Enugu, Nigeria.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted among randomly selected community pharmacists in Enugu, Nigeria. The data obtained were analysed descriptively.</p><p><strong>Key findings: </strong>Approximately 25% of pharmacists perform depression screening, and 14.4% refer clients to psychiatrists. Pharmacists rarely provide information on antidepressant dosage, side effects, frequency, and duration.</p><p><strong>Conclusion: </strong>Community pharmacists in Enugu are not providing effective care to depressed patients. Thus, appropriate interventions are recommended.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"186-189"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138803085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we do better? Sustainability and efficiency in intervention development and implementation. 我们能做得更好吗?制定和实施干预措施的可持续性和效率。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riae004
Carmel M Hughes, Cristín A Ryan
{"title":"Can we do better? Sustainability and efficiency in intervention development and implementation.","authors":"Carmel M Hughes, Cristín A Ryan","doi":"10.1093/ijpp/riae004","DOIUrl":"10.1093/ijpp/riae004","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"107-108"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139746660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing pharmacists' roles in preventing prescription and over-the-counter opioid misuse: a systematic review and narrative synthesis. 影响药剂师在预防处方和非处方阿片类药物滥用中发挥作用的因素:系统综述和叙述性综述。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riad090
Ogochukwu Fidelia Offu, Shelina Visram, Adam Pattison Rathbone, Laura Lindsey

Background: The prescribing rate of opioids is increasing and is a main contributor to opioid misuse. Community pharmacists can help reduce opioid misuse rates by carrying out prescription and over-the-counter (OTC) opioid misuse prevention services. Understanding the barriers and facilitators to community pharmacists' involvement has the potential to improve these services.

Objective: To review the literature on the barriers and facilitators of community pharmacists' involvement in prescription and OTC opioid misuse prevention.

Methods: A systematic review of primary research was carried out in MEDLINE, Embase, Scopus, Web of Science, CINAHL, and APA PsycINFO from January 2022 to March 2022. Narrative synthesis underpinned by the COM-B model was used to analyse findings from the included articles. Studies were included if they used qualitative or mixed methods; published in English and focussed on OTC or prescription opioids.

Results: Ten studies were included in the review. Barriers and facilitators were grouped into individual, environmental, and system-level factors. Based on the COM-B model, these factors were classified as capabilities (knowledge and skill), opportunities (e.g. relationship with prescribers, time), and motivation (pharmacists' attitude).

Conclusion: Improving pharmacists' capabilities and opportunities might improve pharmacists' motivation to offer opioid misuse services. This could improve pharmacists' behaviour, that is, their role in preventing prescription and OTC opioid misuse. The findings of this review were based on information obtained from primary evidence from qualitative studies; However. further empirical work is needed to identify how pharmacists can be supported.

背景:阿片类药物的处方率不断上升,是造成阿片类药物滥用的主要原因。社区药剂师可以通过开展处方药和非处方药 (OTC) 滥用预防服务,帮助降低阿片类药物滥用率。了解社区药剂师参与的障碍和促进因素有可能改善这些服务:回顾有关社区药剂师参与处方药和非处方药阿片类药物滥用预防工作的障碍和促进因素的文献:方法:从 2022 年 1 月至 2022 年 3 月,在 MEDLINE、Embase、Scopus、Web of Science、CINAHL 和 APA PsycINFO 中对主要研究进行了系统综述。以 COM-B 模型为基础的叙事综合法用于分析所纳入文章的研究结果。采用定性或混合方法、以英语发表、关注非处方药或处方阿片类药物的研究均被纳入:结果:10 项研究被纳入审查范围。障碍和促进因素分为个人、环境和系统层面的因素。根据 COM-B 模型,这些因素被分为能力(知识和技能)、机会(如与处方者的关系、时间)和动机(药剂师的态度):结论:提高药剂师的能力和机会可提高药剂师提供滥用阿片类药物服务的积极性。这可以改善药剂师的行为,即他们在预防处方药和非处方药阿片类药物滥用方面的作用。本综述的结论基于从定性研究的主要证据中获得的信息;然而,还需要进一步的实证工作来确定如何为药剂师提供支持。
{"title":"Factors influencing pharmacists' roles in preventing prescription and over-the-counter opioid misuse: a systematic review and narrative synthesis.","authors":"Ogochukwu Fidelia Offu, Shelina Visram, Adam Pattison Rathbone, Laura Lindsey","doi":"10.1093/ijpp/riad090","DOIUrl":"10.1093/ijpp/riad090","url":null,"abstract":"<p><strong>Background: </strong>The prescribing rate of opioids is increasing and is a main contributor to opioid misuse. Community pharmacists can help reduce opioid misuse rates by carrying out prescription and over-the-counter (OTC) opioid misuse prevention services. Understanding the barriers and facilitators to community pharmacists' involvement has the potential to improve these services.</p><p><strong>Objective: </strong>To review the literature on the barriers and facilitators of community pharmacists' involvement in prescription and OTC opioid misuse prevention.</p><p><strong>Methods: </strong>A systematic review of primary research was carried out in MEDLINE, Embase, Scopus, Web of Science, CINAHL, and APA PsycINFO from January 2022 to March 2022. Narrative synthesis underpinned by the COM-B model was used to analyse findings from the included articles. Studies were included if they used qualitative or mixed methods; published in English and focussed on OTC or prescription opioids.</p><p><strong>Results: </strong>Ten studies were included in the review. Barriers and facilitators were grouped into individual, environmental, and system-level factors. Based on the COM-B model, these factors were classified as capabilities (knowledge and skill), opportunities (e.g. relationship with prescribers, time), and motivation (pharmacists' attitude).</p><p><strong>Conclusion: </strong>Improving pharmacists' capabilities and opportunities might improve pharmacists' motivation to offer opioid misuse services. This could improve pharmacists' behaviour, that is, their role in preventing prescription and OTC opioid misuse. The findings of this review were based on information obtained from primary evidence from qualitative studies; However. further empirical work is needed to identify how pharmacists can be supported.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"133-145"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139039879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of pharmaceutical services in the fight against COVID-19 in universal public health systems: a rapid review. 全民公共卫生系统中抗击 COVID-19 的药品服务管理:快速审查。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riad093
Júlia Vasconcellos Augusti, Sarah Nascimento Silva

Introduction: The coronavirus disease 2019 (COVID-19) pandemic brought new challenges and lessons were learnt for health services. In the field of pharmaceutical care, several interventions have been proposed to optimize and expand the response capacity of services.

Objective: To identify and characterize interventions performed in the management of pharmaceutical services during the COVID-19 pandemic in universal public health systems.

Methods: A rapid literature review was conducted and registered in PROSPERO (CRD42022360902). Systematic searches in the MEDLINE (PubMed), Embase, and Virtual Health Library databases were conducted to identify interventions and practices adopted for the management of pharmaceutical care during the COVID-19 pandemic.

Results: Thirteen articles reporting interventions developed in six countries were included. The interventions were summarized under three major themes: actions for continuous access to medicines, logistical measures for acquisition and storage, and organizational strategies. Telepharmacy services stand out as a typical action adopted in different services, which highlights the use and consolidation of digital technologies in these services. Strategies for process management were described and focused on the reorganization of the internal service of pharmacies, flow of services, and people management.

Conclusions: Many interventions were developed during the pandemic, some of which have already been incorporated into routine service delivery. Although the studies did not measure the effect of each intervention, the strategies developed are a source of information for the future delivery of care. Studies should be conducted to evaluate the potential of similar interventions in other health emergency contexts.

导言:2019 年冠状病毒病(COVID-19)大流行为医疗服务带来了新的挑战和教训。在药品护理领域,提出了若干干预措施,以优化和扩大服务的应对能力:目的:确定并描述在 COVID-19 大流行期间,全民公共卫生系统在药品服务管理方面采取的干预措施:方法:进行快速文献综述并在 PROSPERO(CRD42022360902)中登记。在 MEDLINE (PubMed)、Embase 和虚拟健康图书馆数据库中进行了系统检索,以确定在 COVID-19 大流行期间为管理药品护理而采取的干预措施和做法:结果:共收录了 13 篇报道六个国家制定的干预措施的文章。这些干预措施被归纳为三大主题:持续获取药品的行动、采购和储存的后勤措施以及组织战略。远程药学服务是不同服务机构采取的典型行动,突出了数字技术在这些服务机构中的应用和整合。此外,还介绍了流程管理策略,重点是药房内部服务重组、服务流程和人员管理:结论:大流行期间制定了许多干预措施,其中一些已被纳入日常服务中。虽然这些研究没有衡量每项干预措施的效果,但所制定的策略为今后提供护理服务提供了信息来源。应开展研究,评估类似干预措施在其他紧急卫生状况下的潜力。
{"title":"Management of pharmaceutical services in the fight against COVID-19 in universal public health systems: a rapid review.","authors":"Júlia Vasconcellos Augusti, Sarah Nascimento Silva","doi":"10.1093/ijpp/riad093","DOIUrl":"10.1093/ijpp/riad093","url":null,"abstract":"<p><strong>Introduction: </strong>The coronavirus disease 2019 (COVID-19) pandemic brought new challenges and lessons were learnt for health services. In the field of pharmaceutical care, several interventions have been proposed to optimize and expand the response capacity of services.</p><p><strong>Objective: </strong>To identify and characterize interventions performed in the management of pharmaceutical services during the COVID-19 pandemic in universal public health systems.</p><p><strong>Methods: </strong>A rapid literature review was conducted and registered in PROSPERO (CRD42022360902). Systematic searches in the MEDLINE (PubMed), Embase, and Virtual Health Library databases were conducted to identify interventions and practices adopted for the management of pharmaceutical care during the COVID-19 pandemic.</p><p><strong>Results: </strong>Thirteen articles reporting interventions developed in six countries were included. The interventions were summarized under three major themes: actions for continuous access to medicines, logistical measures for acquisition and storage, and organizational strategies. Telepharmacy services stand out as a typical action adopted in different services, which highlights the use and consolidation of digital technologies in these services. Strategies for process management were described and focused on the reorganization of the internal service of pharmacies, flow of services, and people management.</p><p><strong>Conclusions: </strong>Many interventions were developed during the pandemic, some of which have already been incorporated into routine service delivery. Although the studies did not measure the effect of each intervention, the strategies developed are a source of information for the future delivery of care. Studies should be conducted to evaluate the potential of similar interventions in other health emergency contexts.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"109-119"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Career outlook and satisfaction in the presence of workload intensification-a survey of early career pharmacists. 工作量加重情况下的职业前景和满意度--对早期职业药剂师的调查。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riad084
Fiona Bradley, Michael Hammond, Rhiannon Braund

Background: The demographics of the pharmacy workforce is changing with an increased proportion of pharmacists less than 30 years old (early career pharmacists-ECPs). In parallel, the profession has experienced workload intensification and workforce attrition. It is important to understand ECPs career satisfaction to retain this section of the pharmacy profession.

Objectives: This study aimed to collect data on the current career satisfaction of ECPs, and identify workplace factors that were most important to this group. Further, to use these findings to inform sector recommendations.

Methods: A steering group of ECPs in Aotearoa New Zealand developed a survey based on one used previously. An invitation email was sent to all pharmacists who had been registered for less than 10 years and were members of the Pharmaceutical Society of New Zealand.

Results: A total of 1418 ECPs were identified and invited to participate, and responses were received by 416 of these. While 90% believe that they are making a useful contribution to the health of their patients, over half are unhappy and discontented, with over a third dissatisfied with their careers. A large proportion (44%) were considering leaving the profession in the next 5 years. The top three factors for career satisfaction were ability to progress and learn new skills, the people they work with, and the remuneration.

Conclusions: This study provides a starting point for understanding the current environment and level of dissatisfaction of young pharmacists. There are several areas of concern that need to be addressed if a strong vibrant viable pharmacy profession is to be achieved.

背景:药剂师队伍的人口结构正在发生变化,30 岁以下的药剂师(早期职业药剂师-ECPs)所占比例越来越大。与此同时,药剂师职业也经历了工作量增加和人员流失的过程。了解早期职业药剂师的职业满意度对于留住这部分药剂师非常重要:本研究旨在收集有关 ECPs 当前职业满意度的数据,并确定对这一群体最重要的工作场所因素。此外,还将利用这些调查结果为部门建议提供依据:方法:新西兰奥特亚罗瓦地区的 ECP 指导小组根据以前使用过的调查方法制定了一项调查。向所有注册时间不足 10 年且为新西兰药剂师协会会员的药剂师发送了邀请电子邮件:共确定并邀请了 1418 名 ECP 参与调查,其中 416 名收到了回复。虽然 90% 的人认为他们为患者的健康做出了有益的贡献,但超过一半的人感到不开心和不满,超过三分之一的人对自己的职业感到不满。很大一部分人(44%)考虑在未来 5 年内离开这一行业。对职业满意度最高的三个因素是进步和学习新技能的能力、与他们共事的人以及薪酬:这项研究为了解当前环境和青年药剂师的不满意程度提供了一个起点。如果要建立一个强大的、充满活力的、有生命力的药剂师行业,有几个方面的问题需要解决。
{"title":"Career outlook and satisfaction in the presence of workload intensification-a survey of early career pharmacists.","authors":"Fiona Bradley, Michael Hammond, Rhiannon Braund","doi":"10.1093/ijpp/riad084","DOIUrl":"10.1093/ijpp/riad084","url":null,"abstract":"<p><strong>Background: </strong>The demographics of the pharmacy workforce is changing with an increased proportion of pharmacists less than 30 years old (early career pharmacists-ECPs). In parallel, the profession has experienced workload intensification and workforce attrition. It is important to understand ECPs career satisfaction to retain this section of the pharmacy profession.</p><p><strong>Objectives: </strong>This study aimed to collect data on the current career satisfaction of ECPs, and identify workplace factors that were most important to this group. Further, to use these findings to inform sector recommendations.</p><p><strong>Methods: </strong>A steering group of ECPs in Aotearoa New Zealand developed a survey based on one used previously. An invitation email was sent to all pharmacists who had been registered for less than 10 years and were members of the Pharmaceutical Society of New Zealand.</p><p><strong>Results: </strong>A total of 1418 ECPs were identified and invited to participate, and responses were received by 416 of these. While 90% believe that they are making a useful contribution to the health of their patients, over half are unhappy and discontented, with over a third dissatisfied with their careers. A large proportion (44%) were considering leaving the profession in the next 5 years. The top three factors for career satisfaction were ability to progress and learn new skills, the people they work with, and the remuneration.</p><p><strong>Conclusions: </strong>This study provides a starting point for understanding the current environment and level of dissatisfaction of young pharmacists. There are several areas of concern that need to be addressed if a strong vibrant viable pharmacy profession is to be achieved.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"164-169"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139106113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectives of community pharmacists on extended pharmacy services and value-added services in Malaysia: a cross-sectional survey. 马来西亚社区药剂师对扩展药房服务和增值服务的看法:横断面调查。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riad087
Jianfeng Chu, Mari Kannan Maharajan, Kingston Rajiah

Objective: This study aimed to investigate patterns of extended pharmacy services (EPS) provided by Malaysian community pharmacists and their willingness to provide value-added services (VAS) in addition to EPS. Additionally, this study examined the barriers to the effective implementation of these two services.

Method: A cross-sectional survey was conducted using a self-administered questionnaire among community pharmacists in Selangor and Kuala Lumpur. Convenience sampling was done, and descriptive statistics and correlation analysis were performed.

Results: Two hundred and thirty-six pharmacists participated. The most rendered EPS were nutritional supplements, hypertension management, and diabetic management, while chronic kidney disease management, smoking cessation, and mental health services were the least rendered. Pharmacists were willing to provide medication waste management and vaccination as VAS but were less inclined towards therapeutic drug monitoring and sterile compounding. Barriers included limited access to medical records of patients, lack of designated counselling areas, and concerns about remuneration. High sales pressure and busy workloads were additional barriers to providing VAS. Continuous professional development (CPD) positively influenced pharmacists' engagement in EPS and VAS.

Conclusions: This study highlights service provision trends and areas for improvement. Addressing identified barriers, such as enhancing access to patient records and establishing designated counselling areas, can improve service delivery. Remuneration models and workload management strategies should be considered to alleviate barriers related to sales pressure and time constraints. Promoting CPD opportunities is crucial for enhancing pharmacist engagement and optimizing EPS and VAS.

研究目的本研究旨在调查马来西亚社区药剂师提供扩展药房服务(EPS)的模式,以及他们在 EPS 之外提供增值服务(VAS)的意愿。此外,本研究还探讨了有效实施这两项服务的障碍:方法:采用自填问卷的方式对雪兰莪州和吉隆坡的社区药剂师进行了横向调查。进行了方便抽样,并进行了描述性统计和相关分析:236 名药剂师参与了调查。提供最多的 EPS 是营养补充剂、高血压管理和糖尿病管理,而提供最少的是慢性肾病管理、戒烟和心理健康服务。药剂师愿意提供药物废物管理和疫苗接种服务,但不太愿意提供治疗药物监测和无菌配制服务。障碍包括查阅病人病历的机会有限、缺乏指定的咨询区以及对报酬的担忧。销售压力大和工作繁忙是提供增值服务的额外障碍。持续专业发展(CPD)对药剂师参与易感基因检测和自愿咨询有积极影响:本研究强调了服务提供的趋势和需要改进的地方。解决已发现的障碍,如加强对患者病历的访问和建立指定的咨询区,可以改善服务的提供。应考虑薪酬模式和工作量管理策略,以减轻与销售压力和时间限制有关的障碍。促进持续专业发展机会对于提高药剂师的参与度以及优化 EPS 和 VAS 至关重要。
{"title":"Perspectives of community pharmacists on extended pharmacy services and value-added services in Malaysia: a cross-sectional survey.","authors":"Jianfeng Chu, Mari Kannan Maharajan, Kingston Rajiah","doi":"10.1093/ijpp/riad087","DOIUrl":"10.1093/ijpp/riad087","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate patterns of extended pharmacy services (EPS) provided by Malaysian community pharmacists and their willingness to provide value-added services (VAS) in addition to EPS. Additionally, this study examined the barriers to the effective implementation of these two services.</p><p><strong>Method: </strong>A cross-sectional survey was conducted using a self-administered questionnaire among community pharmacists in Selangor and Kuala Lumpur. Convenience sampling was done, and descriptive statistics and correlation analysis were performed.</p><p><strong>Results: </strong>Two hundred and thirty-six pharmacists participated. The most rendered EPS were nutritional supplements, hypertension management, and diabetic management, while chronic kidney disease management, smoking cessation, and mental health services were the least rendered. Pharmacists were willing to provide medication waste management and vaccination as VAS but were less inclined towards therapeutic drug monitoring and sterile compounding. Barriers included limited access to medical records of patients, lack of designated counselling areas, and concerns about remuneration. High sales pressure and busy workloads were additional barriers to providing VAS. Continuous professional development (CPD) positively influenced pharmacists' engagement in EPS and VAS.</p><p><strong>Conclusions: </strong>This study highlights service provision trends and areas for improvement. Addressing identified barriers, such as enhancing access to patient records and establishing designated counselling areas, can improve service delivery. Remuneration models and workload management strategies should be considered to alleviate barriers related to sales pressure and time constraints. Promoting CPD opportunities is crucial for enhancing pharmacist engagement and optimizing EPS and VAS.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"146-155"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138803090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study. 药物审查过程中产生的活动术语标准化的分类开发:德尔菲研究。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riae002
Mohammed S Alharthi, Sion Scott, Carmel Hughes, Christine Bond, Ernieda Hatah, Linda Bryant, Richard Holland, Sam Kosari, Wasim Baqir, Yoon Loke, David Wright

Background: Medication review (MR) is the systematic assessment of a patient's medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact.

Aim: To develop an international taxonomy of standardized terms and activity definitions related to medication reviews.

Method: This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions.

Results: Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education.

Conclusion: Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.

背景:用药审查(MR)是由医护人员对患者用药的安全性和有效性进行的系统性评估。用于描述 MR 活动(如停药和增加剂量)的语言应在各项研究中保持一致,以帮助研究人员比较不同服务的运作方式并确定其影响机制:方法:这是一项基于德尔菲共识的三阶段研究,由国际药物评论专家参与。系统综述为调查提供了 MR 活动术语。专家们用李克特量表对每个活动术语及其定义的共识进行评分,并提供书面反馈。专家组的共识率为 75%。每个阶段都会保留共识要素,并根据反馈意见修改定义:本研究共招募了 7 位专家(回复率为 15.2%),他们分别来自 4 个国家:英国(4 位)、新西兰(1 位)、澳大利亚(1 位)和马来西亚(1 位)。以下术语达成了共识:"用药"(Medication)作为 MR 术语的描述词;"停药"、"开始用药"、"增加剂量"、"减少剂量"、"改变剂型 "和 "药物安全性和有效性监测 "用于描述 MR 活动;"教育"(Educate)用于描述医护人员和患者/护理人员的教育:结论:我们选择了标准化的用药回顾活动术语和定义,供今后所有的 MR 研究普遍采用,以便对不同环境下的过程评估进行有意义的比较。
{"title":"Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study.","authors":"Mohammed S Alharthi, Sion Scott, Carmel Hughes, Christine Bond, Ernieda Hatah, Linda Bryant, Richard Holland, Sam Kosari, Wasim Baqir, Yoon Loke, David Wright","doi":"10.1093/ijpp/riae002","DOIUrl":"10.1093/ijpp/riae002","url":null,"abstract":"<p><strong>Background: </strong>Medication review (MR) is the systematic assessment of a patient's medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact.</p><p><strong>Aim: </strong>To develop an international taxonomy of standardized terms and activity definitions related to medication reviews.</p><p><strong>Method: </strong>This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions.</p><p><strong>Results: </strong>Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education.</p><p><strong>Conclusion: </strong>Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"180-185"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139931071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consumer knowledge of mental health conditions, awareness of mental health support services, and perception of community pharmacists' role in mental health promotion. 消费者对精神健康状况的了解、对精神健康支持服务的认识以及对社区药剂师在促进精神健康方面作用的看法。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riad091
Judith Singleton, Julie E Stevens, Raymond Truong, Adam McCulloch, Elay Ara, Maria B Cooper, Britany Hobbs, Elizabeth Hotham, Vijayaprakash Suppiah

Objective: To explore community pharmacy consumers' knowledge and attitudes of mental illness, support services, and community pharmacists' role in supporting people living with mental illness (PLMI).

Methods: This survey was conducted in 15 community pharmacies between June and September 2019. Participants were aged 18 years or older without prior or ongoing history of mental illness and/or with close family members with mental illness. Open-ended responses to the anonymous questionnaire were analysed using content analysis.

Key findings: Majority of the 380 participants were female (57.4%) with a mean age 52.9 years and 33.7% having completed university. Most (70.3%) believed that people with mental illness had a negative image due to poor health literacy providing possible solutions of 'awareness campaigns', 'education and training', and 'increased government funding for mental health (MH) support services'. Only 33.7% and 63.7% of participants were aware of Mental Health Week and the R U OK? Campaign, respectively. Whilst 12.4% of participants had participated in MH campaigns, only 3.4% were aware of community pharmacists-led MH educational activities. There were significant differences between adults (<65 years) and older adults (≥65 years old) with the latter reporting a more negative image for mental illness (P < 0.05) and having less exposure and engagement with MH resources (P < 0.001) and campaigns (P < 0.01).

Conclusion: Despite awareness, participants reported low engagement with MH campaigns. Additionally, older adults had lower MH literacy and exposure to resources and campaigns. This study highlighted that the community lacked awareness of what pharmacists can offer to support PLMIs.

目的探讨社区药房消费者对精神疾病、支持服务以及社区药剂师在支持精神疾病患者(PLMI)方面所扮演角色的认识和态度:本次调查于 2019 年 6 月至 9 月期间在 15 家社区药房进行。参与者年龄在 18 岁或 18 岁以上,既往无精神病史,也无精神病史和/或近亲中有精神病患者。采用内容分析法对匿名问卷的开放式回答进行了分析:在 380 名参与者中,大多数为女性(57.4%),平均年龄为 52.9 岁,33.7%完成了大学学业。大多数人(70.3%)认为,精神疾病患者的负面形象是由于健康知识匮乏造成的,并提出了 "提高认识运动"、"教育和培训 "以及 "增加政府对精神健康(MH)支持服务的拨款 "等可能的解决方案。只有 33.7% 和 63.7% 的参与者知道心理健康周和 R U OK?运动。虽然有 12.4% 的参与者参加过精神健康运动,但只有 3.4% 的参与者了解由社区药剂师主导的精神健康教育活动。成年人之间存在明显差异(结论:尽管参与者有所了解,但他们对心理健康教育活动的参与度较低。此外,老年人的心理健康知识水平较低,接触资源和活动的机会也较少。这项研究强调,社区缺乏对药剂师可为 PLMI 提供哪些支持的认识。
{"title":"Consumer knowledge of mental health conditions, awareness of mental health support services, and perception of community pharmacists' role in mental health promotion.","authors":"Judith Singleton, Julie E Stevens, Raymond Truong, Adam McCulloch, Elay Ara, Maria B Cooper, Britany Hobbs, Elizabeth Hotham, Vijayaprakash Suppiah","doi":"10.1093/ijpp/riad091","DOIUrl":"10.1093/ijpp/riad091","url":null,"abstract":"<p><strong>Objective: </strong>To explore community pharmacy consumers' knowledge and attitudes of mental illness, support services, and community pharmacists' role in supporting people living with mental illness (PLMI).</p><p><strong>Methods: </strong>This survey was conducted in 15 community pharmacies between June and September 2019. Participants were aged 18 years or older without prior or ongoing history of mental illness and/or with close family members with mental illness. Open-ended responses to the anonymous questionnaire were analysed using content analysis.</p><p><strong>Key findings: </strong>Majority of the 380 participants were female (57.4%) with a mean age 52.9 years and 33.7% having completed university. Most (70.3%) believed that people with mental illness had a negative image due to poor health literacy providing possible solutions of 'awareness campaigns', 'education and training', and 'increased government funding for mental health (MH) support services'. Only 33.7% and 63.7% of participants were aware of Mental Health Week and the R U OK? Campaign, respectively. Whilst 12.4% of participants had participated in MH campaigns, only 3.4% were aware of community pharmacists-led MH educational activities. There were significant differences between adults (<65 years) and older adults (≥65 years old) with the latter reporting a more negative image for mental illness (P < 0.05) and having less exposure and engagement with MH resources (P < 0.001) and campaigns (P < 0.01).</p><p><strong>Conclusion: </strong>Despite awareness, participants reported low engagement with MH campaigns. Additionally, older adults had lower MH literacy and exposure to resources and campaigns. This study highlighted that the community lacked awareness of what pharmacists can offer to support PLMIs.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"170-179"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139032271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacists' role and experiences with delivering mental health care within team-based primary care settings during the COVID-19 pandemic. 在 COVID-19 大流行期间,药剂师在以团队为基础的初级医疗机构中提供心理健康护理的角色和经验。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-03-06 DOI: 10.1093/ijpp/riad086
Rachelle Ashcroft, Annalise Mathers, Amanda Gin, Simon Lam, Catherine Donnelly, Judith Belle Brown, Toula Kourgiantakis, Kavita Mehta, Jennifer Rayner, Deepy Sur, Keith Adamson, Anne Kirvan, Lisa Dolovich

Objectives: Pharmacists have been increasingly integrated into primary care teams, leading to improved health outcomes for patients. The two objectives of this study were (i) to describe how the COVID-19 pandemic impacted pharmacists' role in mental health care within Canadian primary care teams and (ii) to describe Canadian pharmacists' experiences collaborating with other healthcare providers in the delivery of mental health services during the COVID-19 pandemic.

Methods: Cross-sectional observational study utilizing an online survey consisting of closed-ended and open-ended questions. Primary care pharmacists in Ontario were eligible to participate. Descriptive statistics were collated, and qualitative data underwent thematic analysis. A total of 51 pharmacists participated in the study.

Key findings: The COVID-19 pandemic has led to the expanding role of pharmacists in attending to the mental health care of patients. Working within a collaborative, interprofessional healthcare environment, pharmacists support patients' mental health in a variety of ways, including medication education and management, non-pharmacologic approaches and supportive conversations, and identification of resources, including referrals, wellness checks, and consulting with physicians. Increasing demand for mental health services has led to higher referrals to pharmacists, which will likely persist and require further education of pharmacists in mental health along with better access to deliver virtual care.

Conclusion: In response to the increasing mental health care needs of patients since the COVID-19 pandemic, primary care pharmacists reported increased attention spent on mental health care. Building capacity and ensuring support for pharmacists to continue to address the increasing mental health care demands is essential.

目标:药剂师已越来越多地融入初级医疗团队,从而改善了患者的健康状况。本研究的两个目标是:(i) 描述 COVID-19 大流行如何影响药剂师在加拿大初级医疗团队中的心理保健角色;(ii) 描述加拿大药剂师在 COVID-19 大流行期间与其他医疗服务提供者合作提供心理保健服务的经验:方法:横断面观察研究,采用由封闭式和开放式问题组成的在线调查。安大略省的初级保健药剂师均有资格参与。对描述性统计数据进行了整理,并对定性数据进行了主题分析。共有 51 名药剂师参与了研究:COVID-19 大流行使得药剂师在为患者提供心理健康护理方面的作用不断扩大。药剂师在跨专业合作的医疗保健环境中工作,以多种方式为患者的心理健康提供支持,包括药物教育和管理、非药物治疗方法和支持性谈话,以及确定资源,包括转诊、健康检查和向医生咨询。对心理健康服务需求的增加导致了药剂师转诊量的增加,这种情况很可能会持续下去,这就需要对药剂师进行心理健康方面的进一步教育,同时提供更好的虚拟医疗服务:自 COVID-19 大流行以来,患者对心理健康护理的需求不断增加,为应对这种情况,初级保健药剂师报告称,他们对心理健康护理的关注度有所提高。培养药剂师的能力并确保为其提供支持以继续满足日益增长的精神健康护理需求至关重要。
{"title":"Pharmacists' role and experiences with delivering mental health care within team-based primary care settings during the COVID-19 pandemic.","authors":"Rachelle Ashcroft, Annalise Mathers, Amanda Gin, Simon Lam, Catherine Donnelly, Judith Belle Brown, Toula Kourgiantakis, Kavita Mehta, Jennifer Rayner, Deepy Sur, Keith Adamson, Anne Kirvan, Lisa Dolovich","doi":"10.1093/ijpp/riad086","DOIUrl":"10.1093/ijpp/riad086","url":null,"abstract":"<p><strong>Objectives: </strong>Pharmacists have been increasingly integrated into primary care teams, leading to improved health outcomes for patients. The two objectives of this study were (i) to describe how the COVID-19 pandemic impacted pharmacists' role in mental health care within Canadian primary care teams and (ii) to describe Canadian pharmacists' experiences collaborating with other healthcare providers in the delivery of mental health services during the COVID-19 pandemic.</p><p><strong>Methods: </strong>Cross-sectional observational study utilizing an online survey consisting of closed-ended and open-ended questions. Primary care pharmacists in Ontario were eligible to participate. Descriptive statistics were collated, and qualitative data underwent thematic analysis. A total of 51 pharmacists participated in the study.</p><p><strong>Key findings: </strong>The COVID-19 pandemic has led to the expanding role of pharmacists in attending to the mental health care of patients. Working within a collaborative, interprofessional healthcare environment, pharmacists support patients' mental health in a variety of ways, including medication education and management, non-pharmacologic approaches and supportive conversations, and identification of resources, including referrals, wellness checks, and consulting with physicians. Increasing demand for mental health services has led to higher referrals to pharmacists, which will likely persist and require further education of pharmacists in mental health along with better access to deliver virtual care.</p><p><strong>Conclusion: </strong>In response to the increasing mental health care needs of patients since the COVID-19 pandemic, primary care pharmacists reported increased attention spent on mental health care. Building capacity and ensuring support for pharmacists to continue to address the increasing mental health care demands is essential.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"156-163"},"PeriodicalIF":1.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138803095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1